Sivakumar Periasamy - Concepedia

Author

Sivakumar Periasamy

The University of Texas Medical Branch at Galveston ORCID

Also Known As

Ha B, Ha, Brendan, Jasvir Parmar, Periasamy S, Periasamy Sivakumar, Periasamy. S, S Periasamy, S. Periasamy, Sivakumar Periasamy, Sivakumar Periasamy (2572756)

Publications

1.3K

Citations

H-Index

Concepts

All Affiliations

The University of Texas Medical Branch at Galveston Albany Medical Center Hospital Galveston College Indian Veterinary Research Institute Icahn School of Medicine at Mount Sinai

About

Sivakumar Periasamy is an author at The University of Texas Medical Branch at Galveston specializing in medicine, immunology, and inflammation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	21	778
2	Education	2	2	52
3	Allergy	2	2	65
4	Public Health	1	1	37
5	Biology	1	1	37

Sivakumar Periasamy

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
A live-attenuated SARS-CoV-2 vaccine candidate with accessory protein deletions Yang Liu, Xianwen Zhang, Jianying Liu, Nature Communications	2022	96
Cytokine profiles, apoptosis and pathology of experimental Pasteurella multocida serotype A1 infection in mice P. Ezhil Praveena, Sivakumar Periasamy, Anand Kumar, Research in Veterinary Science InflammationGranulocytePathogenesisImmunologyPathology	2010	91
Programmed Death 1 and Cytokine Inducible SH2-Containing Protein Dependent Expansion of Regulatory T Cells Upon Stimulation With Mycobacterium tuberculosis Sivakumar Periasamy, Rohan Dhiman, Peter F. Barnes, The Journal of Infectious Diseases Mycobacterium Tuberculosis InfectionAdaptive Immune SystemT-regulatory CellImmune RegulationImmunology	2011	68
NK1.1+ Cells and IL-22 Regulate Vaccine-Induced Protective Immunity against Challenge with <i>Mycobacterium tuberculosis</i> Rohan Dhiman, Sivakumar Periasamy, Peter F. Barnes, The Journal of Immunology Adaptive Immune SystemT-regulatory CellInnate Immune SystemImmunologyImmune Regulation	2012	67
Antibody effector functions are associated with protection from respiratory syncytial virus Yannic C. Bartsch, Deniz Cizmeci, Jaewon Kang, Cell VaccinationRespiratory Virus ImmunityAntibody Effector FunctionsMedicineImmunology	2022	56
Efficient discovery of SARS-CoV-2-neutralizing antibodies via B cell receptor sequencing and ligand blocking Andrea R. Shiakolas, Kevin J. Kramer, Nicole V. Johnson, Nature Biotechnology Ligand BlockingVaccine TargetImmunologyAntibody EngineeringSars-cov-2-neutralizing Antibodies	2022	53
Development of a rapid point-of-care test that measures neutralizing antibodies to SARS-CoV-2 Douglas F. Lake, Alexa J. Roeder, Erin Kaleta, Journal of Clinical Virology	2021	48
Inhibition of CD23-mediated IgE transcytosis suppresses the initiation and development of allergic airway inflammation Senthilkumar Palaniyandi, Xiaoming Liu, Sivakumar Periasamy, Mucosal Immunology InflammationCd23-mediated Ige TranscytosisInflammatory Lung DiseaseAllergyLung Inflammation	2015	45
Mycobacterium avium subsp. paratuberculosis invades through M cells and enterocytes across ileal and jejunal mucosa of lambs Duraisamy Ponnusamy, Sivakumar Periasamy, Bhupendra Nath Tripathi, Research in Veterinary Science Mycobacterium Avium SubspMicrobial DiseaseM CellsVeterinary SciencePathology	2012	44
Asymptomatic SARS-CoV-2 Infection Is Associated With Higher Levels of Serum IL-17C, Matrix Metalloproteinase 10 and Fibroblast Growth Factors Than Mild Symptomatic COVID-19 Alessandra Soares‐Schanoski, Natalie Sauerwald, Carl Goforth, Frontiers in Immunology Young AdultsViral DiagnosticsSerum Il-17cImmunologyHumoral Response	2022	39

Page 1